| Aug 19 |
Estee Lauder, Liquidia, B. Riley fall premarket; AMD rises
|
| Aug 19 |
3 US Growth Companies With High Insider Ownership
|
| Aug 19 |
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
|
| Aug 16 |
Liquidia draws bullish view at Raymond James on Yutrepia potential
|
| Aug 16 |
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
|
| Aug 13 |
Liquidia surges after sealed document as investors await FDA Yutrepia decision
|
| Aug 10 |
Liquidia Corporation (NASDAQ:LQDA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
|
| Aug 9 |
Why Is Liquidia Corporation (LQDA) The Best Among Caligan Partners’ Top Holdings?
|
| Aug 9 |
Analysts Just Slashed Their Liquidia Corporation (NASDAQ:LQDA) EPS Numbers
|
| Aug 8 |
Liquidia Corporation (LQDA) Q2 2024 Earnings Call Transcript
|
